NewsUnited States
OpenConverge Bio raises $25M Series A to scale sequence-trained generative AI for antibody design and protein optimization
Converge Bio raised a $25M Series A led by Bessemer to scale sequence-trained generative AI across discovery-to-manufacturing. It already ships antibody-design and protein-yield tools.